BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 8790398)

  • 1. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM.
    Vogt AB; Kropshofer H; Moldenhauer G; Hämmerling GJ
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9724-9. PubMed ID: 8790398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
    Schafer PH; Green JM; Malapati S; Gu L; Pierce SK
    J Immunol; 1996 Dec; 157(12):5487-95. PubMed ID: 8955198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM.
    Weber DA; Evavold BD; Jensen PE
    Science; 1996 Oct; 274(5287):618-20. PubMed ID: 8849454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.
    Patil NS; Pashine A; Belmares MP; Liu W; Kaneshiro B; Rabinowitz J; McConnell H; Mellins ED
    J Immunol; 2001 Dec; 167(12):7157-68. PubMed ID: 11739539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DM can partially replace the invariant chain for HLA-DR transport and surface expression in transfected endocrine epithelial cells.
    Serradell L; Muntasell A; Catálfamo M; Martí M; Costa M; de Préval C; Jaraquemada D
    Tissue Antigens; 1999 May; 53(5):447-58. PubMed ID: 10372540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DM stabilizes empty HLA-DR molecules in a chaperone-like fashion.
    vogt AB; Moldenhauer G; Hämmerling GJ; Kropshofer H
    Immunol Lett; 1997 Jun; 57(1-3):209-11. PubMed ID: 9232453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide.
    Sherman MA; Weber DA; Jensen PE
    Immunity; 1995 Aug; 3(2):197-205. PubMed ID: 7648393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading.
    van Ham SM; Tjin EP; Lillemeier BF; Grüneberg U; van Meijgaarden KE; Pastoors L; Verwoerd D; Tulp A; Canas B; Rahman D; Ottenhoff TH; Pappin DJ; Trowsdale J; Neefjes J
    Curr Biol; 1997 Dec; 7(12):950-7. PubMed ID: 9382849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs.
    van Ham SM; Grüneberg U; Malcherek G; Bröker I; Melms A; Trowsdale J
    J Exp Med; 1996 Nov; 184(5):2019-24. PubMed ID: 8920889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the HLA-DM interaction site on HLA-DR molecules.
    Doebele RC; Busch R; Scott HM; Pashine A; Mellins ED
    Immunity; 2000 Oct; 13(4):517-27. PubMed ID: 11070170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
    Kropshofer H; Vogt AB; Thery C; Armandola EA; Li BC; Moldenhauer G; Amigorena S; Hämmerling GJ
    EMBO J; 1998 Jun; 17(11):2971-81. PubMed ID: 9606180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides.
    Pashine A; Busch R; Belmares MP; Munning JN; Doebele RC; Buckingham M; Nolan GP; Mellins ED
    Immunity; 2003 Aug; 19(2):183-92. PubMed ID: 12932352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular and cell surface heterotypic associations of human leukocyte antigen-DR and human invariant chain.
    Triantafilou K; Triantafilou M; Wilson KM; Cherry RJ; Fernandez N
    Hum Immunol; 1999 Nov; 60(11):1101-12. PubMed ID: 10600008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DM.
    Verreck FA; Fargeas CA; Hämmerling GJ
    Eur J Immunol; 2001 Apr; 31(4):1029-36. PubMed ID: 11298327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH.
    Kropshofer H; Arndt SO; Moldenhauer G; Hämmerling GJ; Vogt AB
    Immunity; 1997 Mar; 6(3):293-302. PubMed ID: 9075930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules.
    Denzin LK; Hammond C; Cresswell P
    J Exp Med; 1996 Dec; 184(6):2153-65. PubMed ID: 8976171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J; König A; Koch N
    Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
    Ghosh P; Amaya M; Mellins E; Wiley DC
    Nature; 1995 Nov; 378(6556):457-62. PubMed ID: 7477400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.